TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
2.100
+0.020 (0.96%)
Jan 13, 2026, 4:00 PM EST - Market closed
TherapeuticsMD Revenue
TherapeuticsMD had revenue of $784.00K in the quarter ending September 30, 2025, with 43.33% growth. This brings the company's revenue in the last twelve months to $2.80M, up 75.19% year-over-year. In the year 2024, TherapeuticsMD had annual revenue of $1.76M with 35.25% growth.
Revenue (ttm)
$2.80M
Revenue Growth
+75.19%
P/S Ratio
8.68
Revenue / Employee
$2,796,000
Employees
1
Market Cap
24.31M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.76M | 459.00K | 35.25% |
| Dec 31, 2023 | 1.30M | -68.66M | -98.14% |
| Dec 31, 2022 | 69.96M | 67.39M | 2,619.12% |
| Dec 31, 2021 | 2.57M | -62.30M | -96.03% |
| Dec 31, 2020 | 64.87M | 15.23M | 30.67% |
| Dec 31, 2019 | 49.65M | 33.55M | 208.38% |
| Dec 31, 2018 | 16.10M | -678.25K | -4.04% |
| Dec 31, 2017 | 16.78M | -2.58M | -13.32% |
| Dec 31, 2016 | 19.36M | -786.45K | -3.90% |
| Dec 31, 2015 | 20.14M | 5.12M | 34.05% |
| Dec 31, 2014 | 15.03M | 6.25M | 71.23% |
| Dec 31, 2013 | 8.78M | 4.96M | 129.85% |
| Dec 31, 2012 | 3.82M | 1.73M | 82.84% |
| Dec 31, 2011 | 2.09M | 846.26K | 68.14% |
| Dec 31, 2010 | 1.24M | - | - |
| Dec 31, 2008 | - | - | - |
| Dec 31, 2007 | - | - | - |
| Dec 31, 2006 | - | - | - |
| Dec 31, 2005 | 941.86K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
TXMD News
- 2 months ago - TherapeuticsMD Announces Third Quarter 2025 Financial Results - Business Wire
- 5 months ago - TherapeuticsMD Announces Second Quarter 2025 Financial Results - Business Wire
- 8 months ago - TherapeuticsMD Announces First Quarter 2025 Financial Results - Business Wire
- 10 months ago - TherapeuticsMD Announces Full Year 2024 Financial Results - Business Wire
- 1 year ago - TherapeuticsMD Announces Third Quarter 2024 Financial Results - Business Wire
- 1 year ago - TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying - Benzinga
- 1 year ago - TherapeuticsMD Announces Second Quarter 2024 Financial Results - Business Wire
- 1 year ago - TherapeuticsMD Announces First Quarter 2024 Financial Results - Business Wire